Asahi Kasei, Bluestar form joint ventures for China mPPE business

Nurluqman Suratman

05-Sep-2017

SINGAPORE (ICIS)–Asahi Kasei has entered into a joint venture deal with China National Bluestar (Group) Co Ltd to produce and sell modified polyphenylene ether (mPPE) in China, the Japanese producer said on Tuesday.

The companies aim to produce 30,000 tonnes/year of polymer PPE (polyphenylene ether) and 20,000 tonnes/year mPPE.

Financial details of the deal were not disclosed.

“Asahi Kasei and Bluestar will now begin studying the construction of manufacturing facilities for 2,6-xylenol, PPE, and mPPE, and proceed with detailed evaluation of the economics of the joint business targeting a final investment decision by March 2018,” Asahi Kasei said.

Production will use Bluestar’s technology for 2,6-xylenol and PPE, together with Asahi Kasei’s mPPE compounding technology and applications development capability “to facilitate further expansion in the growing Chinese market”, Asahi Kasei said.

Asahi Kasei and Bluestar created two joint venture firms to separately handle the manufacturing and sales of mPPE operations in China.

Bluestar is a subsidiary of China National Chemical Corp (ChemChina).

Additional reporting by Pearl Bantillo

READ MORE

ICIS Premium news service

The subscription platform provides access to our full range of breaking news and analysis

Contact us now to find out more

Speak with ICIS

Now, more than ever, dynamic insights are key to navigating complex, volatile commodity markets. Access to expert insights on the latest industry developments and tracking market changes are vital in making sustainable business decisions.

Want to learn about how we can work together to bring you actionable insight and support your business decisions?

Need Help?

Need Help?